Ho Tony W Insider Trades

Insider Trading History

Track insider trading activity for Ho Tony W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
ITeos Therapeutics
ITeos Therapeutics ITOS
Director
Holding Value $246k 24,200 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 24,200 shares
$16.32
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Director
Holding Value $227k 22,383 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$331k 22,383 shares
$14.77
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Director
Holding Value $178k 17,538 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$329k 17,538 shares
$18.78
$10.15
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.98M 52,364 shares
Last Trade
Dec 06, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$872k 12,607 shares
$69.17
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $3.7M 64,971 shares
Last Trade
Dec 03, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.74M 53,334 shares
$70.09
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $786k 13,800 shares
Last Trade
Oct 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 13,800 shares
$97.00
$56.95
ITeos Therapeutics
ITeos Therapeutics ITOS
Director
Holding Value $46.3k 4,560 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 4,560 shares
$26.03
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Director
Holding Value $0 0 shares
Last Trade
Apr 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$801k 33,217 shares
$24.11
$10.15
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $1.33M 23,334 shares
Last Trade
Mar 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.33M 32,334 shares
$133.88
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.18M 38,304 shares
Last Trade
Mar 10, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$266k 2,141 shares
$124.15
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.3M 40,445 shares
Last Trade
Mar 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$569k 4,583 shares
$124.15
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.13M 37,447 shares
Last Trade
Mar 05, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$382k 3,333 shares
$114.65
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.04M 35,862 shares
Last Trade
Mar 05, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$182k 1,585 shares
$114.65
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $13.5M 236,449 shares
Last Trade
Dec 21, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.93M 23,551 shares
$166.84
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $3.18M 55,815 shares
Last Trade
Dec 21, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.93M 23,551 shares
$166.84
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $3.28M 57,515 shares
Last Trade
Dec 21, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.93M 23,551 shares
$166.84
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $949k 16,666 shares
Last Trade
Oct 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 16,666 shares
$86.75
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $1.92M 33,747 shares
Last Trade
Jun 23, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$521k 6,929 shares
$75.20
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.32M 40,676 shares
Last Trade
Jun 22, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.1k 229 shares
$70.14
$56.95
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Executive Vp, Head Of R&d
Holding Value $2.33M 40,905 shares
Last Trade
May 26, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$428k 6,100 shares
$70.14
$56.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up